News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

01/11/2021 | CureVac AG

CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection

Data provided further evidence on immunogenicity and protective efficacy of CVnCoV Induction of robust antibody and T cell responses at lower dose than tested in Pha...
01/07/2021 | CureVac AG | Bayer AG

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV - joint press release

Companies enter into a collaboration and services agreement Bayer to support CureVac in numerous areas, including development and supply of CVnCoV CureVac benefits...
01/05/2021 | Atriva Therapeutics GmbH

Atriva Therapeutics obtains approval from German authorities for Phase II trial in COVID-19 patients, led by Charité Clinic in Berlin

RESPIRE is a placebo-controlled, international, multi-center trial treating hospitalized patients with moderate to severe COVID-19 The Phase II clinical trial will e...
12/23/2020 | Ovesco Endoscopy AG

Ovesco HemoPill® acute shows promising results in emergency upper GI hemorrhage diagnostics and in detection of active bleeding in the small intestine

Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal (GI) bleeding was successfully used in a multicentric data collection with 61 pa...
12/04/2020 | CureVac AG

CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer

12/03/2020 | Ovesco Endoscopy AG

OTSC® superior to TAE in refractory peptic ulcer bleeding – study shows significantly lower in-hospital mortality and shorter ICU stay

Compared to patients treated with transcatheter arterial embolization (TAE) for refractory peptic ulcer bleedings, OTSC® showed higher efficacy (72.5% vs. 62.5% (p = 0.47...
12/02/2020 | Immatics

Immatics Announces Third Quarter 2020 Financial Results and Business Update

ACTengine® IMA200 clinical trial series continues scaling globally; initial analysis for patients in ACTengine® dose escalation is on track for Q1 2021 Expansi...
Six people are standing in the bright corridor of a building and facing the camera.
11/30/2020 | BioRegio STERN Management GmbH

“The positive advances in technology deserve to be nurtured. AIQNET is a key project in our hospital.”

AIQNET is a digital ecosystem that facilitates the cross-sectoral use of medical data in line with data protection regulations. It focuses on structuring data with artifi...
11/23/2020 | CureVac AG

CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate, CVnCoV

Wacker supports CureVac in the production of its mRNA-based vaccine candidate against COVID-19 Manufacturing at Wackers’s biotech site in Amsterdam is scheduled to s...
11/17/2020 | CureVac AG

CureVac Establishes European-Based Network to Ramp Up Manufacturing of its COVID-19 Vaccine Candidate, CVnCoV

Building an integrated European vaccine manufacturing network with experienced partners Managing supply chain risk by collaborating with several partners for each ma...
11/17/2020 | Eberhard Karls Universität Tübingen

The Long Road to Dementia

The chain reaction which leads to toxic protein deposits in Alzheimer’s disease starts even earlier than assumed. Researchers from Tübingen show how this process could be stopped early on.

11/16/2020 | CureVac AG

European Commission Announces That Tomorrow It Will Authorize the Agreement with CureVac for the Supply of up to 405 Million Doses of mRNA-Based COVID-19 Vaccine Candidate, CVnCoV

Contract spans 225 million initial doses and the option for an additional 180 million doses Upfront payment to support financing of advanced clinical development of ...
11/16/2020 | Hahn-Schickard - Institut für Mikroaufbautechnik

Hahn-Schickard produces PCR rapid tests for SARS-CoV-2

The new test system just released to the market on November 16, 2020 as an approved medical product by Sindiag GmbH is safe to operate, time-saving and designed for mobile use.

11/13/2020 | Ovesco Endoscopy AG

EMR+: pilot study evaluating data from the first in human clinical cases shows 100 % R0-resection rate and no severe adverse events

The novel EMR+ technique uses an external additional working channel (AWC®) allowing for tissue retraction and triangulation. This pilot study describes the early safety ...
11/11/2020 | Max-Planck-Institut für Intelligente Systeme

Bioinspired cilia help understand which movement pattern generates maximal fluid flows

Scientists at the Max Planck Institute for Intelligent Systems in Stuttgart, Germany, develop artificial cilia that can be programmed to move in waves. In experiments, th...
11/10/2020 | CureVac AG

CureVac Publishes Detailed Interim Phase 1 Data of its COVID-19 Vaccine Candidate, CVnCoV

Data publication follows positive topline data reported November 2, 2020 Full pre-print manuscript available on medRxiv Company to host conference call and webcast...
11/10/2020 | Immatics

Immatics Presents Phase I Data from ACTolog® Multi-Target Pilot Study IMA101 at the 35th Annual SITC Conference

Multi-target Adoptive Cell Therapy (ACT) with endogenous T cells against defined pHLA targets demonstrates feasibility, tolerability and high T-cell persistence. Cli...
11/05/2020 | Max-Planck-Institut für Entwicklungsbiologie

€10 million ERC synergy grant for internation research team

An international team from Germany, France and the US has been awarded one of the prestigious and highly competitive Synergy Grants of the European Research Council (ERC). The PATHOCOM project, funded...
11/02/2020 | CureVac AG

CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate, CVnCoV

Balanced immune response with strong induction of binding, and neutralizing antibodies and first indications of T cell activation Quality of immune response comparab...
10/30/2020 | Universität Hohenheim

Showcase Bioeconomy: Seaweed as a Sustainable Source of Raw Materials

EU research project with the participation of the University of Hohenheim searches for new, sustainable food additives and packaging materials from seaweeds and seagrasses.

 

Load more